#BEGIN_DRUGCARD DB02809

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H24BrN4O6

# Chemical_IUPAC_Name:
2,4-diamino-5-[(4-bromo-3-{[(4S)-4,6-dicarboxylatohexyl]oxy}-5-methoxyphenyl)methyl]pyrimidin-1-ium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Brodimoprim-4,6-Dicarboxylate

# HET_ID:
BDM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H25BrN4O6/c1-30-14-8-11(7-13-10-24-20(23)25-18(13)22)9-15(17(14)21)31-6-2-3-12(19(28)29)4-5-16(26)27/h8-10,12H,2-7H2,1H3,(H,26,27)(H,28,29)(H4,22,23,24,25)/p-1/t12-/m0/s1

# InChI_Key:
InChIKey=SZAVCZNFKJSWRN-LBPRGKRZSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2809

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
496.332

# Molecular_Weight_Mono:
495.087922167

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DIS

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.94

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
8.03e-03 g/l

# Primary_Accession_No:
DB02809

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5287754

# PubChem_Substance_ID:
46507558

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00651

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OCCC[C@@H](CCC([O-])=O)C([O-])=O)=C1Br

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:30 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M10922

# Drug_Target_1_GenBank_ID_Protein:
149540

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
folA

# Drug_Target_1_Gene_Sequence:
>492 bp
ATGACCGCATTTTTATGGGCACAGGATCGCGATGGCTTAATTGGCAAAGATGGTCATTTG
CCATGGCATTTACCGGATGATTTACATTATTTCCGGGCGCAGACAGTTGGTAAGATCATG
GTCGTTGGTCGGCGCACCTATGAAAGTTTTCCTAAACGTCCTTTACCTGAGCGAACCAAT
GTTGTTTTGACCCATCAGGAAGACTATCAAGCGCAAGGTGCCGTGGTCGTGCATGATGTT
GCGGCGGTTTTTGCTTATGCTAAGCAGCATCCCGATCAGGAACTGGTCATTGCTGGCGGT
GCACAGATCTTTACGGCTTTTAAAGATGATGTCGATACGTTACTGGTAACACGTTTGGCT
GGCAGTTTTGAAGGCGATACGAAAATGATTCCATTAAACTGGGATGATTTTACCAAAGTC
TCCAGCCGCACCGTTGAAGATACCAATCCGGCGCTGACGCACACTTATGAGGTTTGGCAA
AAGAAGGCTTAA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
10091649	Polshakov VI, Birdsall B, Frenkiel TA, Gargaro AR, Feeney J: Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate. Protein Sci. 1999 Mar;8(3):467-81.
1905571	Carr MD, Birdsall B, Frenkiel TA, Bauer CJ, Jimenez-Barbero J, Polshakov VI, McCormick JE, Roberts GC, Feeney J: Dihydrofolate reductase: sequential resonance assignments using 2D and 3D NMR and secondary structure determination in solution. Biochemistry. 1991 Jun 25;30(25):6330-41.
3928445	Andrews J, Clore GM, Davies RW, Gronenborn AM, Gronenborn B, Kalderon D, Papadopoulos PC, Schafer S, Sims PF, Stancombe R: Nucleotide sequence of the dihydrofolate reductase gene of methotrexate-resistant Lactobacillus casei. Gene. 1985;35(1-2):217-22.
405008	Batley KE, Morris HR: Dihydrofolate reductase from Lactobacillus casei: N-terminal sequence and comparison with the substrate binding region of other reductases. Biochem Biophys Res Commun. 1977 Apr 25;75(4):1010-4.
6815179	Filman DJ, Bolin JT, Matthews DA, Kraut J: Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. II. Environment of bound NADPH and implications for catalysis. J Biol Chem. 1982 Nov 25;257(22):13663-72.
7547901	Morgan WD, Birdsall B, Polshakov VI, Sali D, Kompis I, Feeney J: Solution structure of a brodimoprim analogue in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry. 1995 Sep 19;34(37):11690-702.
9514736	Gargaro AR, Soteriou A, Frenkiel TA, Bauer CJ, Birdsall B, Polshakov VI, Barsukov IL, Roberts GC, Feeney J: The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate. J Mol Biol. 1998 Mar 20;277(1):119-34.
98527	Freisheim JH, Bitar KG, Reddy AV, Blankenship DT: Dihydrofolate reductase from amethopterin-resistant Lactobacillus casei. Sequences of the cyanogen bromide peptides and complete sequences of the enzyme. J Biol Chem. 1978 Sep 25;253(18):6437-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2931

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
18439

# Drug_Target_1_Name:
Dihydrofolate reductase

# Drug_Target_1_Number_of_Residues:
163

# Drug_Target_1_PDB_ID:
1LUD

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00186	DHFR_1

# Drug_Target_1_Protein_Sequence:
>Dihydrofolate reductase
MTAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTN
VVLTHQEDYQAQGAVVVHDVAAVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLA
GSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQKKA

# Drug_Target_1_Reaction:
5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
5,6,7,8-tetrahydrofolate + NADP(+) = 7,8- dihydrofolate + NADPH

# Drug_Target_1_SwissProt_ID:
P00381

# Drug_Target_1_SwissProt_Name:
DYR_LACCA

# Drug_Target_1_Synonyms:
EC 1.5.1.3

# Drug_Target_1_Theoretical_pI:
6.14

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02809
